Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therapies into healthcare systems. In this interview, he reflects on the policy landscape, regulatory challenges, and the future of access to these emerging treatments in the EU.
Drugreporter Café
Welcome to our new live online video show, Drugreporter Café, where we regularly discuss new developments in the world of drug policy with professionals, activists and decision makers. You can also listen to the Drugreporter Café in Podcast format on Spotify or Apple Podcasts!
Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety – An Interview with Ganna Dovbakh
With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovbakh, Chair of the Civil Society Forum on Drugs, about what the strategy means in practice and the role of civil society moving forward.
Dismantling Orbán’s System – Drugreporter interviewed by Arild Knutsen
As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and István Gábor Takács reflect on decades of activism—and explain why they are now taking their fight to the streets to challenge an increasingly repressive system.
“I’m incredibly proud of what we built” — Ann Fordham on Leaving IDPC After 17 Years
After 15 years at the helm of the International Drug Policy Consortium, Ann Fordham is stepping down as Executive Director. Under her leadership, IDPC has grown into one of the most influential global networks advocating for drug policies grounded in human rights, public health, and social justice. In this interview, we reflect on IDPC’s achievements, ongoing challenges, and what lies ahead.
Sabba: Building the Future of Psychedelic Therapy Education” — Interview with Jeremy Rudy
Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.
Communitas – Psychedelics and the Healing Power of Community – In Conversation with Leor Roseman, PhD
Leor Roseman is a psychedelic researcher whose work explores both the individual and collective dimensions of psychedelic experience — from DMT interruption studies to intergroup healing in the Israeli-Palestinian context. In this interview, we discuss how psychedelics may open space not only for personal transformation, but also for collective reconciliation.
Psychedelics Can Provide Spiritual Validation to LGBTQI People – Interview with Jae Sevelius, PhD
Psychedelic therapy can offer spiritual validation and gender euphoria for trans and non-binary people — Jae Sevelius explains what truly affirming psychedelic care means in practice.
With Psychedelics, I Can Truly Help as a Clinical Psychologist” – Interview with Brian Richards, Psy.D.
Clinical psychologist Brian Richards, Psy.D., explains how psychedelics can transform palliative care—from creating truly healing therapeutic spaces to supporting patients facing the end of life.
Religion, Spirituality, and Psychedelics – A Conversation with Hunt Priest & Sughra Ahmed
Two spiritual leaders from different faiths reveal how psychedelics are transforming their understanding of religion, community, and each other — watch Drugreporter’s new interview!
Trauma and Psychedelic Therapy: Why Integration Matters – Interview with Bessel van der Kolk, MD
In Drugreporter’s new interview, trauma expert Bessel van der Kolk, MD explores how the body stores trauma and why integration is essential for healing in psychedelic therapy.
